º£½ÇÉçÇø

Last year's industrial action in Hollywood casts a long shadow

The FTSE 100 engineering firm has reported double-digit organic growth

Management believes a narrower focus will deliver enhanced returns to shareholders

The telecoms company can't generate profitable growth and its German business is dragging down the rest.

The orders continue to roll in for the precision lab tech company with the traditionally strong second half still to come

The company is taking its franchise model further afield

The leverage multiple is expected to contract further

Valuation declines look to be a thing of the past for this little Reit

The oncology giant sees demand for its cancer drugs accelerate and deliver upgrades for the year, but a regulatory hangover dampens enthusiasm

The IT services business has seen its share price weaken significantly in the past few years